These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15572025)

  • 1. Cross-talk between pRb/E2F and Wnt/beta-catenin pathways: E2F1 induces axin2 leading to repression of Wnt signalling and to increased cell death.
    Hughes TA; Brady HJ
    Exp Cell Res; 2005 Feb; 303(1):32-46. PubMed ID: 15572025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2F1 up-regulates the expression of the tumour suppressor axin2 both by activation of transcription and by mRNA stabilisation.
    Hughes TA; Brady HJ
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1267-74. PubMed ID: 15766563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
    Hämmerlein A; Weiske J; Huber O
    Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1).
    Asally M; Yoneda Y
    Exp Cell Res; 2005 Aug; 308(2):357-63. PubMed ID: 15936755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation.
    Yun MS; Kim SE; Jeon SH; Lee JS; Choi KY
    J Cell Sci; 2005 Jan; 118(Pt 2):313-22. PubMed ID: 15615777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation.
    Daniels DL; Weis WI
    Nat Struct Mol Biol; 2005 Apr; 12(4):364-71. PubMed ID: 15768032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-talk between the TGFbeta and Wnt signaling pathways in murine embryonic maxillary mesenchymal cells.
    Warner DR; Greene RM; Pisano MM
    FEBS Lett; 2005 Jul; 579(17):3539-46. PubMed ID: 15955531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt signaling through canonical and non-canonical pathways: recent progress.
    Widelitz R
    Growth Factors; 2005 Jun; 23(2):111-6. PubMed ID: 16019432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia.
    Simon M; Grandage VL; Linch DC; Khwaja A
    Oncogene; 2005 Mar; 24(14):2410-20. PubMed ID: 15735743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-catenin/T-cell factor-mediated transcription is modulated by cell density in human bronchial epithelial cells.
    Steel MD; Puddicombe SM; Hamilton LM; Powell RM; Holloway JW; Holgate ST; Davies DE; Collins JE
    Int J Biochem Cell Biol; 2005 Jun; 37(6):1281-95. PubMed ID: 15778091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.
    González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A
    Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
    Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
    Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer.
    Calvisi DF; Conner EA; Ladu S; Lemmer ER; Factor VM; Thorgeirsson SS
    J Hepatol; 2005 Jun; 42(6):842-9. PubMed ID: 15885355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells.
    Bafico A; Liu G; Goldin L; Harris V; Aaronson SA
    Cancer Cell; 2004 Nov; 6(5):497-506. PubMed ID: 15542433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt-3a regulates chondrocyte differentiation via c-Jun/AP-1 pathway.
    Hwang SG; Yu SS; Lee SW; Chun JS
    FEBS Lett; 2005 Aug; 579(21):4837-42. PubMed ID: 16099458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development.
    Nateri AS; Spencer-Dene B; Behrens A
    Nature; 2005 Sep; 437(7056):281-5. PubMed ID: 16007074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A beta-catenin identified by functional rather than sequence criteria and its role in Wnt/MAPK signaling.
    Kidd AR; Miskowski JA; Siegfried KR; Sawa H; Kimble J
    Cell; 2005 Jun; 121(5):761-72. PubMed ID: 15935762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting Wnt/beta-catenin signaling during gastrulation using RNA interference in mouse embryos.
    Lickert H; Cox B; Wehrle C; Taketo MM; Kemler R; Rossant J
    Development; 2005 Jun; 132(11):2599-609. PubMed ID: 15857914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the Wnt/beta-catenin pathway in autosomal dominant polycystic kidney disease--a cytobiological evaluation of pkd1 gene].
    Sasaki N
    Hokkaido Igaku Zasshi; 2005 Jan; 80(1):103-14. PubMed ID: 15796036
    [No Abstract]   [Full Text] [Related]  

  • 20. E2F1 suppresses Wnt/β-catenin activity through transactivation of β-catenin interacting protein ICAT.
    Wu Z; Zheng S; Li Z; Tan J; Yu Q
    Oncogene; 2011 Sep; 30(37):3979-84. PubMed ID: 21532622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.